| Attribute | Detail | Source |
|---|---|---|
| Legal name | Eternis Fine Chemicals Limited (EFCL) | MCA via Zauba/Tracxn |
| Former name | Hindustan Polyamides & Fibres Limited (HPFL); rebranded Eternis in 2015 | Sustainability Report 2023-24; Yahoo Finance/Newsfile release, 4-Dec-2024 |
| Corporate Identification Number (CIN) | U17120MH1965PLC015806 (registration no. 15806, ROC Mumbai) | MCA via Zauba, Tracxn |
| Incorporation date | 25 February 1965 | MCA via Zauba, TheCompanyCheck, Bloomberg |
| Entry into aroma chemicals | 1988, through acquisition of a chemicals plant at Koregaon-Bhima, Pune. The company describes itself as "born in 1988". | eternis.com "Our Story" |
| Incorporation jurisdiction | Maharashtra, India (Companies Act) | MCA |
| Registered office / HQ | 1004 Peninsula Tower, Peninsula Corporate Park, Ganpatrao Kadam Marg, Lower Parel, Mumbai 400 013, India | eternis.com; Bloomberg |
| Company type (actual) | Unlisted public limited company, closely held by the Mariwala family. Your list says "Public company". That is correct legally (Indian "public limited" status), but the company is not listed on any exchange. | CRISIL rationales; TheCompanyCheck |
| Stock exchange / ticker | None (unlisted). The Bloomberg identifier 1512539D:IN is a private-company ID, not a trading ticker. | Bloomberg |
| ISIN / CUSIP | Not publicly disclosed. No exchange-traded security exists. | — |
| Fiscal year end | 31 March | CRISIL; MCA filings |
| Promoter holding | 94.38% promoters; 5.62% public/non-promoter (2023) | TheCompanyCheck (MCA-derived) |
| Paid-up capital | ₹12.459 lakh (₹1,245,900); authorised capital ₹45.55 crore | Tracxn (MCA-derived), Nov-2025 |
| Employees (latest) | 609 group employees in FY2024 (India 495, UK 114), before the Sharon PC acquisition | Sustainability Report 2023-24 |
| Employees (other data points) | 488 (Apr-2024, standalone); 493 (30-Sep-2024, standalone); "600+" (Dec-2024 press release); ~475 (LeadIQ, Mar-2026, likely LinkedIn-based). Sharon PC alone had 200+ staff in 2023. | TheCompanyCheck; Tracxn; Newsfile; LeadIQ; Newsfile Jul-2023 |
| Statutory auditor | Not publicly disclosed in sources reviewed. It is available in MCA AOC-4 filings. | — |
| Market capitalisation | Not applicable (unlisted). No observable valuation. | — |
| Credit rating | CRISIL A+/Stable (long-term); CRISIL A1 (short-term). Last full rationale Dec-2024; reiterated in Nov-2025. | CRISIL |
| Websites | www.eternis.com (group/India); www.eternis.co.uk (UK); www.sharonpc.com (personal care, now Eternis Personal Care) | Company |
| Last AGM | 6 June 2025 | Tracxn / TheCompanyCheck (MCA) |
The name on the request, "Eternis Fine Chemicals Ltd.", matches an active Indian legal entity exactly. The dossier profiles that entity and its consolidated group.
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Group employees, India + UK (count) | — | 609 | — |
| Standalone India employees (count) | — | 495 | 493 |
FY2023 and FY2025 group counts are not publicly disclosed. The FY2025 standalone figure is Tracxn as of 30-Sep-2024. A post-acquisition consolidated headcount including Sharon PC has not been published.
Eternis Fine Chemicals is a Mumbai-headquartered, Mariwala-family-controlled maker of aroma chemicals: the synthetic fragrance molecules that global flavour and fragrance (F&F) houses blend into perfumes, detergents, soaps and personal care products. It is part of the same promoter family as Marico Limited and positions itself as India's largest aroma-chemical exporter and a top-10 global producer. The company also describes itself as a top-5 *independent* aroma-ingredient company. Its customers include all four of the largest F&F houses: Givaudan, IFF, Firmenich (now dsm-firmenich) and Symrise. Manufacturing capacity is about 75,000 tonnes per year across four Maharashtra plants and Leek, UK. Through the December 2024 acquisition of Sharon Personal Care, rebranded Eternis Personal Care in July 2026, it has added a second business leg in cosmetic preservatives and functional ingredients, with a plant in Italy. Consolidated revenue is roughly ₹1,900–2,300 crore (about US$230–270 million). It is a commodity-to-specialty bridge player whose edge is scale in a few molecules, cost position, and its status as a supplier to the F&F majors.
---
### What the company does
Eternis makes aroma chemicals. These are single-molecule, synthetic or nature-identical odorants such as coumarin, benzyl salicylate, hexyl cinnamic aldehyde, cyclamen aldehyde, phenyl ethyl alcohol, styrallyl acetate and the PTBCHA/OTBCHA cyclohexyl acetates. They are sold as building-block ingredients to fragrance compounders, who formulate them into fragrance oils for consumer goods.
The UK subsidiary at Leek adds aroma chemicals and acetate ester chemicals. Its liquid products serve lubricants, metalworking fluids, surface coatings, cosmetics, oilfield, pharma, paints, leather, explosives, paper, plastics, food and feed, inks, plasticiser replacements and textile auxiliaries (eternis.co.uk).
Since December 2024 the group also makes personal care ingredients through Eternis Personal Care (ex-Sharon Personal Care). The range covers preservative systems, multifunctional ingredients, actives, textures, wet-wipe solutions and sun-care ingredients (Personal Care Magazine / Cosmetics Business, Jul-2026).
### Business and revenue model
| Dimension | Characterisation | Evidence |
|---|---|---|
| Revenue type | Almost entirely product sales. Bulk and specialty chemicals are sold in drums, IBCs and containers. There is no subscription, licensing or service revenue of note. | Product pages; US import manifests show drum/FCL shipments |
| Pricing | Contract and spot pricing with large F&F houses. Raw materials are phenol- and crude-linked. Management has adopted formula-based pricing with key suppliers to reduce margin volatility. | Sustainability Report 2023-24; CRISIL |
| Customer concentration | Preferred supplier to Givaudan, IFF, Firmenich and Symrise. At the UK site, 72% of sales go to multinationals. | CRISIL (2022–2024); eternis.co.uk |
| Product concentration | Top six products make up a sizeable share of turnover. Hydrogenation-chemistry products and salicylates were about half of revenue (FY2022–23) and about one-third (per Dec-2024 rationale). | CRISIL Jul-2022, Oct-2023, Dec-2024 |
| Export orientation | About 75% of turnover is exported (CRISIL, FY2022–FY2024); the company itself states 80%. | CRISIL; company |
| Contract manufacturing | A historic co-production alliance with Firmenich for Hedione® (2005–09). The CEO has signalled an aim to be an "OEM manufacturer of choice". | eternis.com; P&F+ interview, 2024 |
### Value-chain position
Eternis sits in the middle of the fragrance value chain:
**Upstream:** petrochemical intermediates (phenol, toluene derivatives, aldehydes, acetic acid), hydrogen (produced on-site in a captive plant) and palm-derived oleochemicals (100% RSPO mass-balance certified).
**Midstream (Eternis):** multi-step chemical synthesis, including hydrogenation, esterification, condensation and distillation.
**Downstream customers:** fragrance houses compound Eternis molecules into fragrance oils. These are then sold to FMCG brand owners (home care, personal care, fine fragrance).
With Eternis Personal Care, the group also sells directly to cosmetic formulators and brand owners. The SO.F.I.A Cosmétiques joint venture, which offers formulation and finished-product manufacturing in France, extends the group one step further downstream.
### End-markets
| End-market | Exposure | Comment |
|---|---|---|
| Functional fragrance (detergents, soaps, household care) | Core | CRISIL describes this as a "relatively stable" segment that cushions product-concentration risk |
| Fine fragrance | Core | The company says its products go into many leading perfumed brands |
| Personal care / cosmetics (preservatives, actives, textures, wet wipes, sun care) | New since Dec-2024 | Via Eternis Personal Care |
| Food and feed / flavours | Emerging | FSSAI food licence granted for the Kurkumbh plant; UK food-grade approval expected mid-2025 |
| Industrial (lubricants, coatings, inks, plastics, explosives, leather, paper) | UK site | Acetate esters and liquid chemicals from Leek |
### Company self-description vs. independent characterisation
**Company self-description.** No public annual report is available. In its Sustainability Report 2023-24, the company presents itself as a manufacturer of fragrance and personal-care ingredients and states its purpose as "Enriching Lives with Care". Its corporate "DNA" is "Eternally Agile, Forever Customer-Centric". It cites roughly US$233 million in annual sales, 65,000 tonnes of capacity and 80% export share, and calls itself a top-5 independent aroma-ingredient company.
**Independent characterisation.** Eternis is a mid-sized, export-led, scale-commodity aroma chemicals producer working to move up the specialty curve. Its margins have historically been modest for a specialty chemical company: operating margin of 10–15% and PAT margin of 3.4–4.9% over FY2021–FY2024 (CRISIL). That is well below listed Indian peer Privi Speciality, at roughly 22–26% EBITDA. The gap reflects the lower-margin UK business, raw-material pass-through lags, and intense competition from China and from the backward-integrated F&F majors.
The 2024–2026 strategy has four parts:
- a France-based professional CEO;
- the personal-care acquisition;
- the downstream SO.F.I.A joint venture;
- a sustainability-led premium (low-carbon product variants, TfS membership).
Together these amount to a deliberate effort to escape commodity economics. Execution is unproven in public data.